Vaso Corp. (VASO)
OTHER OTC:VASO
Want to see VASO full AI Analyst Report?
VASO Stock Chart & Stats
$0.17
>-$0.01(-2.42%)
At close: 4:00 PM EST
$0.17
>-$0.01(-2.42%)
Day’s Range― - ―
52-Week Range$0.11 - $0.25
Previous CloseN/A
Volume57.70K
Average Volume (3M)98.46K
Market Cap
$34.71M
Enterprise Value$17.39M
Total Cash (Recent Filing)$21.97M
Total Debt (Recent Filing)$2.40M
Price to Earnings (P/E)19.3
Beta0.41
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding175,998,030
10 Day Avg. Volume66,687
30 Day Avg. Volume98,461
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)1.04
Price to Sales (P/S)0.35
P/FCF Ratio3.68
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit0.32
Enterprise Value/Ebitda-27.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage materially reduces refinancing and liquidity risk, giving the company resilience while operating cash flow is volatile. A conservative capital structure preserves optionality to raise funds, invest, or withstand near-term operating drawdowns without immediate solvency pressure.
High Gross MarginsSustained gross margins above 60% indicate strong unit economics or pricing power in core offerings. That margin buffer supports recovery in operating profit if revenue stabilizes, and provides room to invest in product or sales without immediate margin erosion.
Durable Industry ExposureOperating in healthcare information services ties the business to structural digitization and data demand trends. Such secular tailwinds support recurring demand for analytics and information solutions across provider and payer markets over the medium term.
Bears Say
Revenue ContractionSustained revenue decline reduces scale economics and limits ability to absorb fixed costs, constricts reinvestment capacity, and signals weakening demand or execution issues. Continued top-line erosion would make recovering operating leverage harder over the next several quarters.
Negative Operating & Free Cash FlowNegative OCF and FCF materially weaken financial flexibility despite low debt, forcing reliance on external financing or equity to fund operations and capex. This increases execution risk and limits the company's ability to invest in growth or weather further revenue softness.
Deteriorated Operating ProfitabilityA shift from previously strong margins to near-breakeven reflects structural pressure on operating efficiency or cost control. Thin net margins leave little cushion against revenue volatility and raise the risk that shortfalls will quickly translate into losses or require durable cost restructuring.
Vaso News
VASO FAQ
What was Vaso Corp.’s price range in the past 12 months?
Vaso Corp. lowest stock price was $0.10 and its highest was $0.25 in the past 12 months.
What is Vaso Corp.’s market cap?
Vaso Corp.’s market cap is $34.71M.
When is Vaso Corp.’s upcoming earnings report date?
Vaso Corp.’s upcoming earnings report date is Aug 17, 2026 which is in 73 days.
How were Vaso Corp.’s earnings last quarter?
Currently, no data Available
Is Vaso Corp. overvalued?
According to Wall Street analysts Vaso Corp.’s price is currently Overvalued.
Does Vaso Corp. pay dividends?
Vaso Corp. does not currently pay dividends.
What is Vaso Corp.’s EPS estimate?
Vaso Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaso Corp. have?
Vaso Corp. has 175,998,030 shares outstanding.
What happened to Vaso Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vaso Corp.?
Currently, no hedge funds are holding shares in VASO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vaso Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.12%
12-Months-Change
Fundamentals
Return on Equity
6.23%
Trailing 12-Months
Asset Growth
6.51%
Trailing 12-Months
Company Description
Vaso Corp.
Vaso (VASO) is a technology-driven company focused on providing innovative solutions in the healthcare and medical sectors. The company specializes in developing advanced telehealth platforms and medical products that enhance patient care and streamline healthcare operations. Vaso's core offerings include telemedicine software, remote monitoring devices, and health data analytics services that cater to healthcare providers, patients, and medical institutions.
Technical Analysis
Healthcare Triangle
―
HeartBeam
―
VSee Health
―
BullFrog AI Holdings, Inc.
―
Mangoceuticals, Inc.
―